Traders sold shares of Thermo Fisher Scientific Inc (NYSE:TMO) on strength during trading hours on Tuesday. $50.53 million flowed into the stock on the tick-up and $69.03 million flowed out of the stock on the tick-down, for a money net flow of $18.50 million out of the stock. Of all stocks tracked, Thermo Fisher Scientific had the 0th highest net out-flow for the day. Thermo Fisher Scientific traded up $0.02 for the day and closed at $186.02

A number of equities research analysts have weighed in on the company. Deutsche Bank AG set a $200.00 price objective on Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Saturday, June 10th. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 price objective for the company in a research note on Thursday. Wells Fargo & Company reiterated an “outperform” rating and issued a $200.00 price objective (up previously from $195.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 13th. Jefferies Group LLC reiterated a “hold” rating and issued a $175.00 price objective on shares of Thermo Fisher Scientific in a research note on Wednesday, May 17th. Finally, Bank of America Corporation reiterated a “buy” rating and issued a $210.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a research note on Friday, July 21st. One research analyst has rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $191.94.

The company has a market cap of $74.06 billion, a price-to-earnings ratio of 33.072 and a beta of 1.05. The stock’s 50-day moving average price is $177.72 and its 200-day moving average price is $169.01.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.03. The firm had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The firm’s revenue for the quarter was up 10.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.03 EPS. On average, equities research analysts forecast that Thermo Fisher Scientific Inc will post $9.35 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.32%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s payout ratio is currently 10.45%.

In other Thermo Fisher Scientific news, Director Jim P. Manzi sold 11,318 shares of Thermo Fisher Scientific stock in a transaction on Friday, August 18th. The stock was sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the sale, the director now owns 38,757 shares of the company’s stock, valued at approximately $6,702,635.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jim P. Manzi sold 1,000 shares of Thermo Fisher Scientific stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $175.20, for a total value of $175,200.00. Following the sale, the director now directly owns 38,757 shares in the company, valued at approximately $6,790,226.40. The disclosure for this sale can be found here. Insiders have sold a total of 22,738 shares of company stock worth $4,021,512 in the last ninety days. 0.49% of the stock is owned by company insiders.

A number of institutional investors have recently made changes to their positions in the business. Intl Fcstone Inc. bought a new stake in Thermo Fisher Scientific during the 2nd quarter valued at $276,000. Griffin Asset Management Inc. bought a new stake in Thermo Fisher Scientific during the 2nd quarter valued at $209,000. Gs Investments Inc. bought a new stake in Thermo Fisher Scientific during the 2nd quarter valued at $3,260,000. Hall Laurie J Trustee raised its stake in Thermo Fisher Scientific by 4.6% during the 2nd quarter. Hall Laurie J Trustee now owns 2,851 shares of the medical research company’s stock valued at $497,000 after acquiring an additional 125 shares in the last quarter. Finally, Atlantic Trust LLC bought a new stake in Thermo Fisher Scientific during the 2nd quarter valued at $138,000. 83.52% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Traders Sell Shares of Thermo Fisher Scientific Inc (TMO) on Strength (TMO)” was reported by Daily Political and is the property of of Daily Political. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/09/07/traders-sell-shares-of-thermo-fisher-scientific-inc-tmo-on-strength-tmo-2.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.